Label: P32 SODIUM PHOSPHATE injection, suspension
- Category: HUMAN PRESCRIPTION DRUG LABEL
- DEA Schedule: None
- Marketing Status: unapproved drug other
DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
Updated June 19, 2012
If you are a consumer or patient please visit this version.
INDICATIONS AND USAGE
P32 chromic phosphate is indicated for intracavitary instillation for the treatment of peritoneal or pleural effusions caused by metastatic disease, and may be injected interstitially for the treatment of cancer. It is also used in hemophilia patients for intraarticular injections.
- DOSAGE AND ADMINISTRATION
- DECAY CHART
- PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
INGREDIENTS AND APPEARANCE
P32 SODIUM PHOSPHATE
p32 sodium phosphate injection, suspension
Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:51808-127 Route of Administration INTRA-ARTICULAR, INTRAPERITONEAL, INTERSTITIAL, INTRAPLEURAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength PHOSPHORUS P-32 (UNII: 690284A407) (PHOSPHORUS P-32 - UNII:690284A407) PHOSPHORUS P-32 5 mCi in 1 mL Inactive Ingredients Ingredient Name Strength DEXTROSE (UNII: IY9XDZ35W2) 0.3 g in 1 mL BENZYL ALCOHOL (UNII: LKG8494WBH) 0.02 mL in 1 mL SODIUM ACETATE (UNII: 4550K0SC9B) 1 mg in 1 mL Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:51808-127-01 3 mL in 1 VIAL Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date Unapproved drug other 06/19/2012 Labeler - AnazaoHealth Corporation (011038762) Establishment Name Address ID/FEI Business Operations AnazaoHealth Corporation 011038762 MANUFACTURE(51808-127)